Table 2.
The prehospital status of patients.
| Characteristics | Total | NLTX | Placebo | P value |
|---|---|---|---|---|
| n = 27 | n = 27 | |||
| Pre-hospital Apnea | ||||
| No apnea | 43 (79.6%) | 23 (85.2%) | 20 (74.1%) | 0.38‡ |
| One episode | 8 (14.8%) | 2 (7.4%) | 6 (22.2%) | |
| Two episodes | 3 (5.6%) | 2 (7.4%) | 1 (3.7%) | |
| Bradypnea | 27 (50.0%) | 11 (40.7%) | 16 (59.3%) | 0.17* |
| Naloxone doses (mg) | ||||
| Mean ± SD | 1.5 ± 0.8 | 1.5 ± 0.7 | 1.5 ± 1 | 0.53‡ |
| Symptoms | ||||
| Nausea & vomiting | 23 (42.6%) | 13 (48.1%) | 10 (37.0%) | 0.41* |
| Dizziness | 14 (25.9%) | 7 (25.9%) | 7 (25.9%) | >0.99* |
| Headache | 3 (5.6%) | 1 (3.7%) | 2 (7.4%) | >0.99** |
| Seizure | 3 (5.6%) | 2 (7.4%) | 1 (3.7%) | >0.99** |
| Weakness | 5 (9.3%) | 3 (11.1%) | 2 (7.4%) | >0.99** |
| Fall down | 2 (3.7%) | 0 (0.0%) | 2 (7.4%) | 0.49** |
| Pruritus | 2 (3.7%) | 0 (0.0%) | 2 (7.4%) | 0.49** |
†Student's t-test. ‡Mann-Whitney U test. *Chi-Square test. **Fisher's exact test.